Comparing overlapping genes between solid-tumor drug target genes and hematologic-tumor drug target genes revealed that 3 genes (IL2RG, LCK, and VEGFA) were duplicated, which accounted for 60% (3/5, hypergeometric test p = 0.0110, Supplementary Figure 4H) of overlapping genes from the UCEC profile connected to hematologic-tumor drug target genes. This evidence concerns the gene LCK and neoplasm.